Both in Pharmaceuticals
Amarin vs Mereo BioPharma Group
Over the past year AMRN returned −26.8% and MREO returned −84.0%; their daily moves had a correlation of 0.04.
AMRN −26.8% MREO −84.0%Growth of $1, one year, split-adjusted
| Metric | AMRN | MREO |
|---|---|---|
| Price | $11.61 | $0.2830 |
| Market cap | $488.1M | $45.2M |
| Today | +0.30% | +0.93% |
| 1 month | −3.2% | −24.6% |
| 6 months | −22.9% | +13.4% |
| Year to date | −16.8% | −32.1% |
| 1 year | −24.2% | −84.3% |
| Revenue growth (YoY) | −20.4% | — |
| Gross margin | 40.9% | — |
| Net margin | 0.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.8× | — |
| Net cash | $323.4M | — |
| Dividend yield | — | — |
| Volatility (60d) | 31.0% | 78.9% |
| Short % of float | — | — |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).